모노백신(엡스타인-바 바이러스) 시장 : 용도별, 지역별

Monovaccine (Epstein - Barr virus) Market is estimated to be valued at USD 8.34 Bn in 2026 and is expected to reach USD 12.05 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.40% from 2026 to 2033.

Epstein-Barr virus (EBV) infects human B cells and spreads the infection throughout the entire reticuloendothelial system (RES). The virus is known to cause various autoimmune disorders including multiple sclerosis, celiac disease, systemic lupus erythematosus, juvenile idiopathic arthritis, inflammatory bowel disease, rheumatoid arthritis, and type 1 diabetes. Various research studies have linked Epstein-Barr virus to certain cancers of the lymphatic system and lupus. For instance, according to the report from the Cincinnati Children's Hospital Medical Center, in 2018, infection with the Epstein-Barr virus (EBV) increases the risk of developing multiple sclerosis. When the human body encounters foreign bodies such as virus or bacteria, it uses B-cells to produce antibodies to fight against these agents. However, in Epstein-Barr infections, the virus invades and takes control of B-cells. EBV invades B cells by producing abnormal transcription factors that regulate gene expression.

The researchers revealed that virus-derived EBNA2 transcription factor binds to several spots in the human genome that are linked to above mentioned diseases. Moreover, EBV is linked with several human cancers such as Burkitt's lymphoma, nasopharyngeal carcinoma, and post-transplant lymphoproliferative disorder. However, the exact reason for EBV leading to different types of cancers is currently being studied by various researchers. For instance, according to the study published in Gynecologic Oncology Journal, 2017, researchers from the Federal University of Cariri stated that cervical carcinoma was four times more prevalent among EBV positive women than in women without EBV infection. This indicated that EBV infection increases the risk of cervical carcinoma.

Market Dynamics

• Various universities are involved in frequent research and development activities for development of novel monovaccines.
• For instance, since 2017, University of Kansas School of Engineering and School of Pharmacy is studying genetics of human immune responses to produce a potent vaccine for Epstein - Barr virus or EBV. Such increasing research activities by various organizations for development of novel vaccines for EBV is expected to drive the global monovaccines (Epstein - Barr virus) market growth.
• Furthermore, high prevalence of various diseases related to EBV virus is expected to rise demand for its vaccine in future.
• For instance, according to data published by Cancer Research U.K. in 2014, around 62,400 cases of Hodgkin's lymphoma were recorded worldwide, out of which around 28,600 cases were associated with Epstein-Barr virus. According to the same source, it was estimated that EBV is responsible for an estimated 45% of Hodgkin's lymphoma in the U.K., annually.
• According to data published by Cancer Research U.K. in 2014, EBV is a very common virus that can increase the risk of nasopharyngeal cancer. According to same source, there were around 80,000 cases of nasopharyngeal carcinoma worldwide, out of which around 78,100 cases were associated with Epstein-Barr virus.

Key features of the study

• This report provides in-depth analysis of global monovaccine (Epstein-Barr Virus) market and provides market potential (US$ Billion)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global monovaccine (Epstein-Barr Virus) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Universities and organizations involved in development of monovaccine (Epstein-Barr virus) includes Cancer Research U.K., National Institutes of Health, Chinese University of Hong Kong, Genocea Biosciences, Inc., Dana-Farber Cancer Institute, German Cancer Research Institute, and University of Minnesota
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global monovaccine (Epstein-Barr Virus) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global monovaccine (Epstein-Barr Virus) market

Market Segmentation

• By Application
  • Mononucleosis
  • Endemic Burkitt's Lymphoma
  • Hodgkin's Lymphoma
  • Gastric Carcinomas
  • Multiple sclerosis
  • Nasopharyngeal Carcinoma
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • Cancer Research UK
  • National Institutes of Health
  • Chinese University of Hong Kong
  • Genocea Biosciences, Inc.
  • Dana-Farber Cancer Institute
  • German Cancer Research Institute
  • University of Minnesota

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Application
  • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Pipeline Analysis

4. Global Monovaccine (Epstein-Barr Virus) Market, By Application, 2026 -2033 (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-O-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Mononucleosis
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
• Endemic Burkitt's Lymphoma
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
• Hodgkin's Lymphoma
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
• Gastric Carcinomas
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
• Multiple sclerosis
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)
• Nasopharyngeal Carcinoma
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (US$ Bn)

5. Global Monovaccine (Epstein-Barr Virus) Market, By Region

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-O-Y Growth Analysis, For Region, 2026 - 2033
• North America
  • Market Share Analysis, By Country, 2026 and 2033 (%)
  • Y-O-Y Growth Analysis, By Country, 2026 - 2033
    • U.S.
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Canada
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Latin America
  • Market Share Analysis, By Country, 2026 and 2033 (%)
  • Y-O-Y Growth Analysis, By Country, 2026 - 2033
    • Brazil
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Argentina
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Mexico
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Rest of Latin America
  • Country/Region Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Europe
  • Market Share Analysis, By Country, 2026 and 2033 (%)
  • Y-O-Y Growth Analysis, By Country, 2026 - 2033
    • U.K.
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Germany
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Italy
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Spain
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• France
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Russia
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Rest of Europe
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Asia Pacific
  • Market Share Analysis, By Country, 2026 and 2033 (%)
  • Y-O-Y Growth Analysis, By Country, 2026 - 2033
    • China
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• India
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Japan
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• ASEAN
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• South Korea
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Australia
  • Country Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Rest of Asia Pacific
  • Country/Region Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Middle East
  • Market Share Analysis, By Country/Region, 2026 and 2033 (%)
  • Y-O-Y Growth Analysis, By Country/Region, 2026 - 2033
    • GCC
  • Country/Region Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Israel
  • Country/Region Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Rest of Middle East
  • Country/Region Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Africa
  • Market Share Analysis, By Country/Region, 2026 and 2033 (%)
  • Y-O-Y Growth Analysis, By Country/Region, 2026 - 2033
    • Northern Africa
  • Country/Region Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• Central Africa
  • Country/Region Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)
• South Africa
  • Country/Region Trends
  • Market Size and Forecast, By Application, 2026 - 2033 (US$ Bn)

6. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Cancer Research UK
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies
  • National Institutes of Health
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies
  • Chinese University of Hong Kong
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies
  • Genocea Biosciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies
  • Dana-Farber Cancer Institute
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies
  • German Cancer Research Institute
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies
  • University of Minnesota
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Strategies

7. Section

• References
• Research Methodology
• About us and Sales Contact